We validated our results for the identified metabolites in an independent subset of the NEO cohort in individuals without diagnosis of diabetes mellitus that did not use glucose lowering medication using the same indices of glucose metabolism and insulin sensitivity. This evidence concerns the gene INS and diabetes mellitus.